Study Comparing Risperidone vs Placebo as Add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-Optimally Responding to Standard Therapy.

This study has been completed.

Study NCT00086112 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: June 24, 2004 Last Updated: April 23, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2005
Estimated Primary Completion Date:	No date given